Herpes Labialis (Oral Herpes) drugs in development by stages, target, MoA, RoA, molecule type and key players, 2023

The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Herpes Labialis (Oral Herpes) and features dormant and discontinued products.

GlobalData tracks 15 drugs in development for Herpes Labialis (Oral Herpes) by 11 companies/universities/institutes. The top development phase for Herpes Labialis (Oral Herpes) is preclinical with six drugs in that stage. The Herpes Labialis (Oral Herpes) pipeline has 15 drugs in development by companies and 0 by universities/ institutes. Some of the companies in the Herpes Labialis (Oral Herpes) pipeline products market are: Shulov Innovative Science, NanoViricides and Safety Shot.

The key targets in the Herpes Labialis (Oral Herpes) pipeline products market include Prostaglandin G/H Synthase 2 (Cyclooxygenase 2 or COX2 or Prostaglandin Endoperoxide Synthase 2 or PHS II or Prostaglandin H2 Synthase 2 or PTGS2 or EC 1.14.99.1), Cannabinoid Receptor 2 (CB2 or CX5 or CNR2), and DNA Primase (EC 2.7.7.6).

The key mechanisms of action in the Herpes Labialis (Oral Herpes) pipeline product include Cannabinoid Receptor 2 (CB2 or CX5 or CNR2) Agonist with two drugs in Phase I. The Herpes Labialis (Oral Herpes) pipeline products include five routes of administration with the top ROA being Topical and five key molecule types in the Herpes Labialis (Oral Herpes) pipeline products market including Small Molecule, and Synthetic Peptide.

Herpes Labialis (Oral Herpes) overview

Oral herpes is an infection of the lips, mouth, or gums by the herpes simplex virus. Oral herpes is also called herpes labialis. Symptoms include sore throat, fever, swollen glands, and painful swallowing. Treatment includes antiviral medications.

For a complete picture of Herpes Labialis (Oral Herpes)’s pipeline drug market, buy the report here.

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.